What they were paid
Keros Therapeutics Director Compensation Table · the one fiscal year held| Fiscal year | Cash fees | Stock awards | Option awards | Other | Total |
|---|---|---|---|---|---|
| FY2025 | $39,538 | $79,223 | $21,016 | $0 | $139,777 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Keros Therapeutics, Inc. DEF 14A filed April 22, 2026, accession 0001104659-26-046791, and prior-year filings. Open the filing on EDGAR.
How this board is paid
company policy · FY2025Keros Therapeutics pays directors a $41,500 cash retainer and $186,535 in equity.
Committees
FY2025 · as the proxy prints themNominating/Governance (Chair)
The rest of the Keros Therapeutics board
FY2025 · as the company reported each| Director | Role | FY2025 total |
|---|---|---|
| Alpna Seth | Independent Director | $238,535 |
| Charles Newton | Independent Director | $0 |
| Jasbir Seehra | Director | $0 |
| Jean-Jacques Bienaim | Chair of the Board | — |
| Julius Knowles | Independent Director | $239,035 |
| Mary Ann Gray | Independent Director | $247,535 |
| Nima Farzan | Independent Director | $239,035 |
The full Keros Therapeutics compensation record
free company briefThis page is one director within Keros Therapeutics's record. The company brief lists every named executive and director, each linking to their own page.
Velarion Pro: every company page, peer tools and exports, one seat